Table 2.
Differences in junior’s responses on low dose and high doses for quantitative variables
| Differential LD-HD | ||||
|---|---|---|---|---|
| Median [Min.; Max.] (p value) | ||||
| M1 | M2 | M3 | M4 | |
| J1 | − 0.1 [− 5.2; 1.2] (0.415) |
0 [− 2.9; 0.7] (0.492) |
0 [− 0.4; 0.9] (0.503) |
0.05 [− 0.2; 0.5] (0.339) |
| J2 | 0 [− 5; 1.1] (0.683) |
0 [− 1.7; 1.1] (0.863) |
0.1 [− 0.4; 0.3] (0.426) |
0.1 [− 0.2; 0.6] (0.193) |
| J3 | 0.05 [− 4.9; 0.8] (0.943) |
0 [− 2.8; 1.3] (0.447) |
0 [− 1; 9.1] (0.905) |
0.1 [− 0.2; 0.5] (0.117) |
| J4 | 0 [− 5.2; 0.6] (0.538) |
− 0.05 [− 5; 1.8] (0.190) |
− 0.5 [− 0.9; 0.3] (0.554) |
0.1 [− 0.4; 0.5] (0.155) |
| J5 | 0 [− 5.2; 2.9] (0.909) |
− 0.1 [− 1.2; 0.8] (0.034)* |
0.05 [− 0.2; 0.7] (0.320) |
0.1 [− 0.3; 0.6] (0.044) |
LD low dose, HD high dose, Min. minimum, Max. maximum, J1 first junior assessor, J2 second junior assessor; etc., M1 maxillary alveolar bone height, M2 maxillary alveolar bone width, M3 mandibular alveolar bone height, M4 mandibular alveolar bone width
P values of Wilcoxon signed-rank tests comparing LD to HD presented in Italics